Tri Chemical Laboratories announced its results after the market close on 31 August. Ordinary profit for the six months through the second quarter was ¥4.52 billion, up 19.1% year on year, and the full-year profit forecast was revised upward by 38.4% to ¥8.72 billion, with a new record profit expected.
Consolidated ordinary profit for the six months through the second quarter (February-July) came in at ¥4.52 billion, up 19.1% year on year. Revenue increased year on year, while the operating margin declined slightly. The results for the first half were disclosed accordingly, revealing that profit levels during the period had turned toward improvement.
The full-year ordinary profit forecast was revised upward from the previous estimate of ¥6.3 billion to ¥8.72 billion, with profit expected to increase 23.0%. Although profit is expected to rise year on year, the company is now on track to set a new record profit for the third consecutive fiscal year.
For the most recent three months, ordinary profit for May-July was ¥2.04 billion, down 5.5% year on year. Revenue increased, but the operating margin on sales declined from the previous fiscal year.
For the second half of the current fiscal year, the company expects ordinary profit for August-January to increase 27.5% year on year to ¥4.19 billion. At the same time, the results contain points that still warrant caution when assessing second-half performance.